Phibro Animal Health reports Q1 net loss of $8.0M; lowers FY2024 guidance

PHIBRO ANIMAL HEALTH CORP

2024-Q1 EPS reported -$0.20 revenue$231,349,000

Net sales $231.3M (-1% YoY); net loss $8.0M vs $3.9M net income prior year; diluted loss per share $0.20.
Adjusted EBITDA $18.7M (-16% YoY); adjusted diluted EPS $0.14 (-33%).
Animal Health segment sales up 4% to $160.5M; Mineral Nutrition down 6%; Performance Products down 18%.
FY2024 guidance reduced: net sales $980M-$1.02B, adjusted EBITDA $106M-$112M, adjusted diluted EPS $1.04-$1.16.
Results include $10.4M pension settlement charge, $6.7M FX losses; Israel conflict causing manufacturing disruptions.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

PHIBRO ANIMAL HEALTH CORP reported the fiscal quarter ended September 30, 2023 results: revenue $231.3 million, net income Net loss of $8.0 million, EPS Diluted loss per share of $0.20. Guidance reaffirmed.

Period: the fiscal quarter ended September 30, 2023
Revenue: $231.3 million
Net income: Net loss of $8.0 million
EPS: Diluted loss per share of $0.20
Guidance: reaffirmed
Result: reported results

Exact text from the filing

guidance for the year ending June 30, 2024. Highlights for the three months ended September 30, 2023 (compared to the three months ended September 30, 2022) - Net sales of $231.3 million, a decrease of $1.2 million, or 1% - Net loss of $8.0 million, a decrease of $11.9 million - Diluted loss per share of $0.20, a decrease of $0.30 - Adjusted EBITDA of $18.7

View on SEC.gov

Browse all earnings releases →

PHIBRO ANIMAL HEALTH CORP filing history →

Source: SEC EDGAR

accession 0001558370-23-018296

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.